BIOSECURE Act set for Trump’s signature after Congress approval
Poised to become law, the BIOSECURE Act will have ramifications for certain US-China pharmaceutical relationships.
Business & Regulation
EU inches closer to new pharma legislation amid competitiveness drive
BIOSECURE Act set for Congress vote after inclusion in annual defence bill
Former FDA commissioners unite to condemn US vaccine proposals
House passes bill that reauthorises the FDA’s paediatric priority voucher pathway
UK and US strike “landmark” zero-tariff pharma deal
Novo Nordisk latest outlook trim shows “quick momentum loss”
Tidmarsh’s FDA exit marks latest high-profile jockeying at US agencies
